[{"indications": "Indications\u00a0see under Dose", "name": "TOLTERODINE TARTRATE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "7 Obstetrics, gynaecology, and urinary-tract disorders", "7.4 Drugs for genito-urinary disorders", "7.4.2 Drugs for urinary frequency, enuresis, and incontinence", "Urinary incontinence", "TOLTERODINE TARTRATE"], "cautions": "Cautions\u00a0\n(From Urinary incontinence: British National Formulary)\nCautions\u00a0Antimuscarinic drugs should be used with caution in the elderly (especially if frail), in those with autonomic neuropathy, and in those susceptible to angle-closure glaucoma. They should also be used with caution in hiatus hernia with reflux oesophagitis. Antimuscarinics can worsen hyperthyroidism, coronary artery disease, congestive heart failure, hypertension, prostatic hyperplasia, arrhythmias, and tachycardia. For interactions, see Appendix 1 (antimuscarinics).; history of QT-interval prolongation; concomitant\r\nuse with other drugs known to prolong QT interval", "side-effects": "Side-effects\u00a0\n(From Urinary incontinence: British National Formulary)\nSide-effects\u00a0Side-effects of antimuscarinic drugs include dry mouth, gastro-intestinal disturbances including constipation, flatulence, taste disturbances, blurred vision, dry eyes, drowsiness, dizziness, fatigue, difficulty in micturition (less commonly urinary retention), palpitation, and skin reactions (including dry skin, rash, and photosensitivity); also headache, diarrhoea, angioedema, arrhythmias, and tachycardia. Central nervous system stimulation, such as restlessness, disorientation, hallucination, and convulsion may occur; children are at higher risk of these effects. Antimuscarinic drugs can reduce sweating, leading to heat sensations and fainting in hot environments or in patients with fever, and very rarely may precipitate angle-closure glaucoma.; also\r\nchest pain, peripheral oedema; sinusitis, bronchitis; paraesthesia,\r\nfatigue, vertigo, weight gain; flushing also reported", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/70146.htm", "doses": ["Urinary frequency, urgency, and incontinence, adult over 18 years, 2\u00a0mg twice daily; reduce to\r\n1\u00a0mg twice daily if necessary to minimise side-effects; child 2\u201318 years see BNF for Children", "Nocturnal enuresis associated with overactive bladder, child 5\u201318 years see BNF for Children"], "pregnancy": "Pregnancy\u00a0manufacturer advises avoid\u2014toxicity in animal studies"}, {"indications": "Indications\u00a0see under Dose", "name": "TOLTERODINE TARTRATE Modified release", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "7 Obstetrics, gynaecology, and urinary-tract disorders", "7.4 Drugs for genito-urinary disorders", "7.4.2 Drugs for urinary frequency, enuresis, and incontinence", "Urinary incontinence", "TOLTERODINE TARTRATE", "Modified release"], "cautions": "Cautions\u00a0\n(From Urinary incontinence: British National Formulary)\nCautions\u00a0Antimuscarinic drugs should be used with caution in the elderly (especially if frail), in those with autonomic neuropathy, and in those susceptible to angle-closure glaucoma. They should also be used with caution in hiatus hernia with reflux oesophagitis. Antimuscarinics can worsen hyperthyroidism, coronary artery disease, congestive heart failure, hypertension, prostatic hyperplasia, arrhythmias, and tachycardia. For interactions, see Appendix 1 (antimuscarinics).; history of QT-interval prolongation; concomitant\r\nuse with other drugs known to prolong QT interval", "side-effects": "Side-effects\u00a0\n(From Urinary incontinence: British National Formulary)\nSide-effects\u00a0Side-effects of antimuscarinic drugs include dry mouth, gastro-intestinal disturbances including constipation, flatulence, taste disturbances, blurred vision, dry eyes, drowsiness, dizziness, fatigue, difficulty in micturition (less commonly urinary retention), palpitation, and skin reactions (including dry skin, rash, and photosensitivity); also headache, diarrhoea, angioedema, arrhythmias, and tachycardia. Central nervous system stimulation, such as restlessness, disorientation, hallucination, and convulsion may occur; children are at higher risk of these effects. Antimuscarinic drugs can reduce sweating, leading to heat sensations and fainting in hot environments or in patients with fever, and very rarely may precipitate angle-closure glaucoma.; also\r\nchest pain, peripheral oedema; sinusitis, bronchitis; paraesthesia,\r\nfatigue, vertigo, weight gain; flushing also reported", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/106152.htm", "doses": ["Urinary frequency, urgency, and incontinence, adult over 18 years, 2\u00a0mg twice daily; reduce to\r\n1\u00a0mg twice daily if necessary to minimise side-effects; child 2\u201318 years see BNF for Children", "Nocturnal enuresis associated with overactive bladder, child 5\u201318 years see BNF for Children", "Name[Detrusitol\u00ae XL  (Pharmacia) ] Capsules, blue, m/r, tolterodine tartrate 4\u00a0mg, net price 28-cap pack = \u00a325.78. \r\n    Label:\r\n    3, 25Dose\u00a0urinary frequency, urgency and incontinence, adult over 18 years, 4\u00a0mg once daily"], "pregnancy": "Pregnancy\u00a0manufacturer advises avoid\u2014toxicity in animal studies"}]